A Crack in Creation

A Crack in Creation. A 2017 non-fiction book co-authored by Nobel Prize-winning biochemist Jennifer Doudna and researcher Samuel H. Sternberg. It chronicles the discovery, development, and profound implications of the CRISPR-Cas9 genome editing technology. The work serves as both a scientific memoir and a public primer on a tool that has revolutionized biological research and medical therapeutics.

Overview

The book details the rapid ascent of CRISPR technology from an obscure bacterial immune defense into a precise genetic engineering tool. Doudna and Sternberg narrate the collaborative, yet intensely competitive, international race involving institutions like the University of California, Berkeley, the Broad Institute, and the Max Planck Society. They explain the core mechanism where the guide RNA directs the Cas9 enzyme to make targeted cuts in DNA, enabling the rewriting of the genetic code in organisms ranging from microbes to primates.

Development of CRISPR-Cas9

The narrative traces the foundational work of scientists like Yoshizumi Ishino and Francisco Mojica, who first characterized repetitive sequences in Archaea. Key breakthroughs came from the labs of Emmanuelle Charpentier at the Umeå University and Doudna’s team at the University of California, Berkeley, who reconstituted the system in vitro. Parallel work by Feng Zhang at the Broad Institute demonstrated its function in eukaryotic cells, leading to a historic patent dispute. The book describes the pivotal 2012 publication in the journal *Science* that ignited the field.

Scientific and medical implications

The authors outline transformative applications, including creating models of human diseases in mice and monkeys for research at institutions like the Salk Institute. They highlight potential cures for sickle cell anemia, Beta thalassemia, and Huntington's disease, as well as strategies for combating HIV/AIDS and Zika virus outbreaks. The technology also enables advanced synthetic biology projects and controversial efforts like gene drives to control malaria-carrying mosquitoes.

Ethical and societal considerations

A central theme is the ethical dilemma posed by the technology’s power, particularly following the 2015 International Summit on Human Gene Editing in Washington, D.C.. Doudna recounts her personal alarm over early experiments editing human embryos in China and the specter of non-therapeutic enhancement. The book discusses the need for global governance, involving bodies like the National Academy of Sciences and the World Health Organization, to establish boundaries, especially regarding heritable genetic modifications.

Reception and impact

Upon release, the book was widely reviewed in publications like The New York Times and The Guardian, praised for its accessible explanation of complex science. It received the 2017 Phi Beta Kappa Award in Science. The work significantly influenced public discourse on Bioethics, preceding major events like the 2018 He Jiankui controversy. Doudna’s continued advocacy, through forums like the World Economic Forum, and her 2020 Nobel Prize, have cemented the book’s status as a key document of a scientific revolution.

Category:2017 non-fiction books Category:Books about genetics Category:American science books